Skip to main content
NEXALIS THERAPEUTICS LTD logo

NEXALIS THERAPEUTICS LTD — Investor Relations & Filings

Ticker · NX1 ISIN · AU0000456733 ASX Professional, scientific and technical activities
Filings indexed 509 across all filing types
Latest filing 2026-05-29 Declaration of Voting R…
Country AU Australia
Listing ASX NX1

About NEXALIS THERAPEUTICS LTD

https://nexalistherapeutics.com/

Nexalis Therapeutics Ltd focuses on the discovery and development of innovative small molecule therapies for the treatment of chronic inflammatory and autoimmune diseases. The company utilizes a proprietary drug discovery platform to target specific biological pathways, including the NLRP3 inflammasome, which is implicated in the progression of various systemic and neurodegenerative conditions. By developing highly selective and potent modulators, the organization aims to address significant unmet medical needs in patient populations suffering from debilitating inflammatory disorders. Research and development efforts are centered on translating complex biological insights into clinical-stage therapeutic candidates designed to improve patient outcomes and quality of life through precision targeting of immune system dysregulation.

Recent filings

Filing Released Lang Actions
2026 AGM results 2 pages 190.9KB
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an announcement of the results of the 2026 Annual General Meeting, detailing each resolution, proxy votes, poll results and whether each resolution was carried or withdrawn. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-05-29 English
2026 AGM slides 15 pages 648.2KB
AGM Information Classification · 95% confidence The document is the slide deck/agenda and resolutions presented at the 2026 Annual General Meeting, including voting procedures and Q&A guidance. It is materials shared during an AGM, not the full annual report or other regulatory filing. Therefore it fits the "AGM Information" category.
2026-05-28 English
Binding Letter of Intent to replace existing $53m facility 3 pages 151.1KB
Capital/Financing Update Classification · 97% confidence The document is an ASX announcement dated 28 May 2026 detailing a binding letter of intent for a new $53 million non-dilutive funding facility, replacing an existing debt facility. It describes terms of the financing partnership, facility structure, interest rates, and equity participation for the lender. This clearly pertains to a capital/financing update rather than a full financial report or other corporate action category.
2026-05-27 English
Reinstatement to Official Quotation 1 page 86.1KB
Regulatory Filings Classification · 78% confidence The document is an ASX Market Announcement regarding the reinstatement of trading quotation for Nexalis Therapeutics Ltd following a compliance event. It is a compliance/market notice rather than a substantive financial report, management discussion, or transaction. Thus it falls under general regulatory announcements, best mapped to Regulatory Filings (RNS).
2026-05-27 English
Suspension from Quotation 2 pages 209.5KB
Regulatory Filings Classification · 90% confidence The document is an ASX market announcement regarding the voluntary suspension of the company’s securities under Listing Rule 17.2. It is a compliance/regulatory notice rather than a financial report, board change, or other specific filing type. Therefore it best fits into the general Regulatory Filings (RNS) category.
2026-05-25 English
Trading Halt 2 pages 212.6KB
Regulatory Filings Classification · 90% confidence The document is an ASX Market Announcement notifying a trading halt request for Nexalis Therapeutics Ltd. It is a regulatory announcement relating to continuous disclosure obligations and does not contain substantive financial statements, management commentary, or official report content. This fits the fallback “Regulatory Filings” category for general compliance/regulatory notices.
2026-05-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.